Prontoflex

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prontoflex

Prontoflex is a pharmaceutical product whose active substance is Ketoprofen, a well-established agent used to manage pain, fever, and inflammation.

Property Description
Active ingredient Ketoprofen (INN)
Form Available as oral capsules/tablets, and topical gels/solutions
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Analgesic, Anti-inflammatory, Antipyretic
Origin Synthetic (Propionic acid derivative)

What Type of Medicine is Prontoflex?

Prontoflex is a commercial name for a medication whose active ingredient, Ketoprofen, is formally categorized as a Nonsteroidal Anti-inflammatory Drug (NSAID). Ketoprofen is a synthetic compound belonging to the propionic acid derivatives chemical group, which includes several similar agents used in clinical practice. This classification indicates its action is geared toward modifying the body's natural response to inflammation. Ketoprofen is recognized as effective across multiple administration forms, providing capabilities as an analgesic and antipyretic, in addition to its primary anti-inflammatory function.

Composition and Available Forms of Ketoprofen

The composition of Prontoflex is a single-ingredient product (monotherapy), meaning the therapeutic effect is provided solely by the Ketoprofen component, which is combined with necessary inactive excipients or a non-active vehicle. The substance is available for multiple routes of administration, offering therapeutic flexibility. Forms include oral presentations, such as tablets, as well as topical presentations, such as gels or solutions, allowing for systemic relief or localized application to a painful area. The availability in diverse dosage forms provides options for different delivery needs.

What is the General Therapeutic Purpose of Prontoflex?

The core therapeutic purpose of Prontoflex is to address the three principal components of inflammation: pain, swelling, and fever. Its function is based on the mechanism principle of acting as a Cyclooxygenase (COX) inhibitor, which temporarily modulates the body's inflammatory signaling pathways. By interfering with the biochemical production of prostaglandins—the messengers that intensify pain and swelling—the medication helps to interrupt the pain-swelling cycle, thereby alleviating general discomfort and reducing signs of inflammation.

Regulatory References

  1. NIH LiverTox - Ketoprofen
  2. FDA DailyMed - Ketoprofen

What side effects are possible with Prontoflex?

Possible Side Effects and Safety Information

Prontoflex does not have an established systemic side effect profile in major regulatory databases under this specific name. However, assuming it contains an active pharmaceutical ingredient, the following general safety information is compiled based on regulatory documentation for related drug classes, such as Nonsteroidal Anti-inflammatory Drugs (NSAIDs), to provide a comprehensive safety context.

Serious and Clinically Significant Adverse Reactions

Serious risks associated with the NSAID class include major and potentially fatal cardiovascular and gastrointestinal adverse events.

  • Cardiovascular Thrombotic Events: NSAIDs may increase the risk of serious events, including myocardial infarction (MI) and stroke. The risk can begin early in treatment and may increase with duration and higher doses.
  • Gastrointestinal Risk: NSAIDs carry a documented risk of serious gastrointestinal adverse events, including inflammation, bleeding, ulceration, and perforation of the stomach or intestines, which can occur without warning symptoms.
  • Other Serious Events: Regulatory warnings also cover risks such as new-onset or worsening hypertension, fluid retention, edema, congestive heart failure, and serious skin reactions, including exfoliative dermatitis and toxic epidermal necrolysis.

Key Adverse Reaction Categories

Classification Examples of Documented Reactions
Common Headache, dizziness, dyspepsia, abdominal pain, nausea, diarrhea, constipation, flatulence.
System-Organ Classes Gastrointestinal, Cardiovascular, Nervous System, Skin and Subcutaneous Tissue, Renal.

Safety Considerations and Restrictions

Population-Specific: Use in older adults is associated with a greater risk of serious gastrointestinal events. Exposure during late pregnancy can pose a risk of fetal harm.

Restrictions: The drug class is generally contraindicated just prior to or following coronary artery bypass graft (CABG) surgery due to increased risk of thrombotic events. Caution is required in patients with pre-existing cardiovascular disease, hypertension, heart failure, or kidney/liver impairment. The lowest effective dose should be used for the shortest possible duration to minimize the potential for serious adverse events.

Summary of Safety Profile

The regulatory safety profile of the drug class involves significant warnings focused on cardiovascular and gastrointestinal integrity, requiring careful risk assessment before initiation. Official regulatory documentation emphasizes continuous monitoring for symptoms of serious adverse events throughout the entire treatment course. The risks are dose- and duration-dependent, structuring the understanding of risk relative to exposure.

Overdose and Emergency Response

Overdose Manifestations and Required Actions

The following descriptions of overdose and mandated actions are based exclusively on official government regulatory documents.

Overdose with Ketoprofen (Prontoflex) is officially documented to primarily affect the Gastrointestinal and Central Nervous Systems (CNS). Symptoms reported in the regulatory labeling include nausea, vomiting, stomach pain, diarrhea, drowsiness, dizziness, and lethargy. Less frequently reported manifestations include blurred vision and ringing in the ears (tinnitus).

System Severe Outcomes Documented in Overdose
CNS Seizures and coma
Cardiovascular/Renal Hypotension, hypertension, and acute renal failure
Gastrointestinal Gastrointestinal bleeding and ulceration

When to Seek Immediate Medical Help

Official regulatory guidance requires that an individual with a suspected overdose must seek immediate medical attention and contact emergency services or a poison control center right away. Severe outcomes such as seizures or signs of internal bleeding are documented as potential life-threatening complications requiring urgent hospitalization.

Official Management Procedures

Regulator-approved labeling explicitly states that there is no specific antidote known for a Ketoprofen overdose. Therefore, management must consist entirely of symptomatic and supportive care. Depending on the quantity ingested, medical procedures mentioned in regulatory documents may include the use of activated charcoal and gastric lavage for gastrointestinal decontamination, alongside necessary monitoring of vital signs.

Therapeutic Uses of Prontoflex

Prontoflex (Ketoprofen) is a medication applied for symptomatic support across several key therapeutic areas where symptoms that interfere with daily functioning are present. The medication is utilized to help with a range of acute and chronic symptom patterns.


Key Therapeutic Domains

Prontoflex is commonly used to address symptom clusters that may become intense or disruptive, such as the pain, localized tenderness, and joint stiffness associated with conditions involving inflammatory or irritative processes. This includes managing conditions like osteoarthritis, rheumatoid arthritis, gout flare-ups, and pain from muscle strains or sprains. It is also relevant when symptoms cluster into a pattern of fever and generalized body aches, or for the cramping pain of primary dysmenorrhea. The medication is applied across domains where additional symptomatic support is needed and supports the patient during difficult episodes by easing distress.

“The medication is often applied when symptoms create noticeable physiological strain, and assists with maintaining functional stability.”

Patient Benefit Summary

This medication offers supportive therapeutic benefit for discomfort arising from conditions associated with acute or disruptive episodes, including injury and the postoperative phase. The medication is commonly used to manage symptoms and contributes to improved comfort during periods of heightened discomfort.


Quick Fact: Relief for Inflammatory Discomfort

Prontoflex is commonly used across conditions presenting with acute episodes and those with recurrent or episodic manifestations, such as arthritis and menstrual pain, aiming to provide supportive relief when symptoms interfere with routine activities.

Regulatory References

  1. NIH MedlinePlus overview of Ketoprofen uses

Eligibility and Restrictions for Use

This information details the official regulatory eligibility and contraindications for Prontoflex, a medication classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). Users should strictly follow their prescriber’s instructions.


Eligibility Scope

Classification Description Regulatory Status
Populations Allowed Patients requiring relief from pain and inflammation as directed by a healthcare professional. Generally Eligible
Use Not Recommended Use in the elderly or those with underlying cardiovascular, gastrointestinal, or renal risk factors is strongly cautioned and should be minimized in dose and duration. Requires Special Consideration

Formal Contraindications (Must Not Use)

Prontoflex is formally contraindicated and must not be used in individuals with the following conditions:

  • Hypersensitivity (allergic reactions) to Prontoflex, ketoprofen, or any other NSAID, including a history of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
  • Active Peptic Ulcer, gastrointestinal (GI) bleeding, or perforation.
  • Severe Heart Failure (New York Heart Association Class III-IV).
  • Severe Renal Impairment (Kidney disease).
  • Severe Hepatic Impairment (Liver disease).
  • Conditions with Increased Bleeding Tendency (due to the NSAID's antiplatelet effects).

Condition-Specific Rules

Condition Eligibility Status Detail
Pregnancy Contraindicated Use is prohibited during the third trimester of pregnancy.
Lactation Not Established Use is generally not recommended; a risk-benefit assessment is required as excretion into breast milk may occur.
Age Restricted Pediatric use is generally not established or may be restricted to specific formulations and weight groups, often not recommended for children under 16 years of age.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Prontoflex (Ketoprofen) is defined by documented risks of pharmacodynamic effects and altered clearance of co-administered agents.

Formal Interaction Restrictions

Co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) or high-dose Aspirin is generally not recommended or is formally contraindicated due to the significantly increased risk of serious gastrointestinal events. Prontoflex is also strictly contraindicated for the treatment of peri-operative pain following Coronary Artery Bypass Graft (CABG) surgery.

Documented Pharmacodynamic and Exposure Interactions

Interacting Agent Category Officially Documented Interaction Outcome
Anticoagulants (e.g., Warfarin), Antiplatelet Agents, Corticosteroids, SSRIs Increased risk of hemorrhage, bleeding, or gastrointestinal ulceration.
Diuretics (e.g., Furosemide), ACE Inhibitors, ARBs Reduced efficacy of the co-administered medicine and increased risk of renal impairment or failure.
Lithium and Methotrexate Reduced renal clearance of these agents, leading to elevated plasma concentrations and increased risk of their respective toxicities.

Substance and Population Constraints

Daily use of alcohol increases the risk for serious gastrointestinal adverse events, including bleeding. In the elderly population, the risk for serious GI and cardiovascular adverse events is notably increased when Prontoflex is combined with interacting drugs, requiring appropriate caution as noted in regulatory labeling. The co-administration of Probenecid is not recommended as it significantly reduces Ketoprofen's plasma clearance.

Mechanism of Action

Targeting the Prostaglandin Synthesis Pathway

Prontoflex's core action is as a non-selective competitive inhibitor of the Cyclooxygenase (COX) enzymes, targeting both COX-1 and COX-2. By occupying the active sites of these enzymes, the medication modifies the early molecular steps of the arachidonic acid cascade, thereby restricting the synthesis of various prostaglandins, which function as powerful biological mediators.


Modulating Nociception and Thermoregulation

This mechanistic action leads to two distinct physiological consequences. Peripherally, the reduced prostaglandin level alters the chemical signals that normally sensitize nociceptors (sensory nerve endings), while also decreasing vascular permeability. This results in diminished peripheral nociceptor sensitization and reduced tissue exudation/edema. Centrally, the drug modulates prostaglandin-mediated signaling within the brain's hypothalamus, the area controlling the body's thermal set point. This initiates a predictable physiological adjustment, leading to the establishment of the body's normal temperature set point.

Dosage and Administration Information

How to Use Prontoflex

Prontoflex, which contains the active substance Ketoprofen, is administered through oral and topical/cutaneous routes. The choice of route depends on whether systemic or localized action is required.

Administration and Dosing Regimens

Oral Prontoflex is available in two main forms that govern the dosing schedule. The Immediate-Release (IR) capsules are typically dosed multiple times daily (e.g., every six to eight hours) for acute pain, with standard strengths including 25 mg and 50 mg. The Extended-Release (ER) capsules, generally 200 mg, are used once daily for maintenance therapy of chronic conditions and are not recommended for acute pain. The maximum recommended daily dose for IR forms is 300 mg, while for ER forms it is 200 mg.

Oral forms may be taken with food or milk to help mitigate potential gastrointestinal discomfort. Taking the medication with food slows the rate of absorption but does not typically alter the total amount of medication absorbed by the body.

Population-Specific Instructions

There are specific dose considerations for certain populations. For older adults (geriatric patients), a lower initial dose is generally required, and close monitoring of renal function is recommended due to potential age-related clearance changes. Similarly, patients with severe renal impairment have a maximum daily dose reduction, which should not exceed 100 mg per day in certain cases.

Recent Clinical Evidence

Prontoflex: Recent Clinical Evidence

Prontoflex, a topical formulation containing the non-steroidal anti-inflammatory drug (NSAID) ketoprofen, is designed for local treatment of pain and inflammation, aiming to minimize systemic exposure.

Efficacy in Acute Injuries

Clinical studies have investigated the efficacy of topical ketoprofen, the active ingredient in Prontoflex, particularly in treating acute soft tissue injuries such as ankle sprains and tendinitis. For uncomplicated ankle sprains, a registry study comparing topical ketoprofen spray-gel (Prontoflex) to oral ketoprofen tablets found that the topical application was significantly superior in reducing spontaneous pain and pain on active movement after both three and seven days of treatment. Furthermore, the topical application showed better results concerning secondary parameters like ankle swelling and mobility impairment.

Another randomized, double-blind, placebo-controlled trial supported the use of topical ketoprofen patches for the treatment of symptomatic tendinitis of recent onset. Over a one-to-two-week period, patients treated with the ketoprofen patch demonstrated a significantly greater decrease in pain on daily activities compared to the placebo group.

Safety and Tolerability Profile

The primary advantage of topical NSAIDs like Prontoflex is their localized action, which results in low systemic bioavailability. This is associated with a lower incidence of systemic adverse effects compared to oral NSAIDs. In the aforementioned ankle sprain study, the topical ketoprofen formulation was generally well tolerated, whereas the oral ketoprofen tablets caused gastrointestinal side effects in some patients. The most commonly reported adverse events with topical ketoprofen involve localized reactions such as skin and subcutaneous tissue disorders, which are typically non-severe and often resolve spontaneously.

Frequently Asked Questions (FAQ)

Common questions about Prontoflex (FAQ)


Q: How quickly should I expect Prontoflex to start working?

A: According to regulatory documents, the immediate-release form of Prontoflex’s active ingredient is absorbed rapidly. Official data indicates that the highest concentrations in the blood are reached within 0.5 to 2 hours after taking the medicine by mouth. This indicates the rate at which the medication becomes available in the body.


Q: How long does the effect of one dose of Prontoflex last?

A: Official pharmacological data indicates that the pain-relieving effects from a standard dose of the immediate-release form of the active ingredient typically persist for 4 to 6 hours.


Q: How often is Prontoflex typically taken?

A: The frequency of use is dependent on the specific formulation prescribed. The immediate-release oral form is typically described as being taken multiple times a day (e.g., three to four times daily). The extended-release oral form is typically prescribed for once-a-day use for long-term management.


Q: What is the role of Prontoflex in treating chronic vs. acute conditions?

A: Official prescribing information indicates that the immediate-release formulations are generally used for conditions requiring relief from acute pain and inflammation. In contrast, extended-release forms are typically used for the long-term management of chronic conditions, such as certain types of arthritis.


Q: What is the recommended duration of use for Prontoflex?

A: Regulatory warnings state that the lowest effective amount should be used for the shortest possible duration. This is necessary because the risk of serious side effects, particularly affecting the heart and digestive system, can increase with both the amount used and the duration of use.


Q: What is the maximum recommended duration of treatment with Prontoflex?

A: Official labeling for certain topical formulations may state that if symptoms persist at the end of a specific timeframe, such as 7 days, treatment is typically discontinued, and medical follow-up is necessary. Oral forms generally emphasize the shortest duration possible to mitigate risk.


Q: Is Prontoflex known to cause long-term side effects?

A: Regulatory documents indicate that the risk of certain serious side effects, including heart attack, stroke, and new peptic ulcers, is considered more likely for people who use this class of medicine for a long time. Official documentation emphasizes minimizing the duration of use.


Q: What is the risk of liver problems associated with Prontoflex use?

A: Regulatory documentation reports that minor elevations of liver tests can occur in some patients taking this medication. While rare, severe liver reactions have been reported, including cases of fatal fulminant hepatitis (a serious form of liver inflammation) and liver failure, associated with this drug class.


Q: Can Prontoflex affect my blood pressure?

A: Official warnings state that medicines in this class can cause the new onset of high blood pressure (hypertension) or potentially worsen existing high blood pressure. They may also interfere with the efficacy of certain medications used to treat blood pressure.


Q: Does Prontoflex cause drowsiness or affect my ability to drive?

A: Official documents list side effects that can affect the nervous system, such as drowsiness, dizziness, or fatigue. Official information notes that these effects may impair the ability to drive or operate machinery.


Q: What should I do if I notice a change in my vision while using Prontoflex?

A: Regulatory documents state that if a user experiences any visual changes, such as blurred vision or other visual disturbances, the medicine is typically discontinued, and an ophthalmologic evaluation is performed.


Q: What is the effect of using Prontoflex while drinking alcohol?

A: Regulatory documents state that avoiding alcohol is recommended while taking this medication. Concurrent use is linked to a significant increase in the risk of serious gastrointestinal side effects, including bleeding.


Q: Are there any common foods or drinks that interact with Prontoflex?

A: Regulatory documents indicate that taking the medication with food or milk can help mitigate stomach discomfort, though this may slow the rate of absorption. Alcohol is the primary substance noted for significant interaction risk. No other specific common food or drink restrictions are generally listed.


Q: Are there known drug-herb interactions with Prontoflex?

A: Official sources occasionally list interactions with specific herbal products. For example, products containing willow bark may be advised to be avoided due to the potential for interaction with how the body processes the medication.


Q: Is Prontoflex known to cause weight gain?

A: Official documentation lists adverse effects related to fluid balance, such as fluid retention and edema. Less commonly, regulatory documents may also report general weight gain as a potential side effect.


Q: Is Prontoflex considered a controlled substance?

A: Official regulatory classification in the United States and other regions confirms that the active ingredient in Prontoflex is a prescription-only medicine but is not classified as a controlled substance.


Q: Is it okay to crush or chew Prontoflex tablets?

A: Official administration instructions generally state that oral capsules and tablets, particularly Extended-Release forms, should be swallowed whole. They should not be crushed, split, or chewed, as this can affect how the medicine is released into the body and increase the risk of side effects.


Q: What happens if I forget to take a dose of Prontoflex?

A: Official drug information describes the standard procedure for a missed dose: taking it when remembered, unless it conflicts with the next dose, in which case the missed dose is typically omitted. Two doses are generally not taken at the same time. This is standard guidance found in regulatory documents.


Q: Is Prontoflex available as a generic medicine?

A: Yes, official drug information and reference resources indicate that a lower-cost generic version of the active ingredient in Prontoflex is generally available.


Q: What is the difference between Prontoflex and a standard NSAID?

A: Prontoflex’s active ingredient, Ketoprofen, is formally categorized as a Nonsteroidal Anti-inflammatory Drug (NSAID). Prontoflex is therefore a specific member of the NSAID drug group, possessing properties and approved uses described in its regulatory label.


Q: What happens in the body when Prontoflex starts to work?

A: The medicine works by modifying the body’s inflammatory signals, specifically by reducing the production of chemical messengers called prostaglandins. This action leads to diminished nerve sensitivity and a reduction in swelling at the site of discomfort.

How should Prontoflex be stored and disposed of?

Storage and Disposal Information

Prontoflex (Ketoprofen) must be stored strictly according to official regulatory requirements to maintain product stability.


Official Storage Conditions

Requirement Specification
Temperature Store at controlled room temperature, typically 20 C to 25 C.
Protection Keep from freezing and store away from heat, moisture, and direct light.
Container Keep the medicine in its original container and ensure it is tightly closed.
Safety The product must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Prontoflex must be disposed of in accordance with local regulations. Do not dispose of this medicine in the household trash or by flushing it into wastewater. Consult a pharmacist or healthcare professional for designated collection points for proper pharmaceutical waste handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prontoflex found in:

A-Z Index: